HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Omega-3/Heart Disease Amended Health Claim Without Disclaimer Proposed

This article was originally published in The Tan Sheet

Executive Summary

FDA should amend the approved health claim linking omega-3 fatty acids to a reduced risk of coronary heart disease by removing the disclaimer and extending the claim to foods, supplement industry members maintain in a June 23 petition

You may also be interested in...



Industry Qualifies Enthusiasm For Omega-3 Qualified Health Claim

FDA's qualified health claim linking omega-3 fatty acids to coronary heart disease too narrowly interprets the beneficial relationship, dietary supplement industry stakeholders contend

Martek Casts For CHD Reduction Claim For Fish Oils, Big Disclaimer For Fish

Fish oil products and supplements containing omega-3 fatty acids would be exempt from lengthy disclaimers when using qualified coronary heart disease reduction claims, while fish would not, under a proposal submitted to FDA by Martek Biosciences

Omega-3 claims petition

FDA has filed health claim petition "for conventional foods and dietary supplements relating consumption of omega-3 fatty acids...to reduced risk of coronary heart disease," agency states in Sept. 3 letter to Washington, D.C. law firm Emord & Associates. Emord submitted petition June 23 on behalf of Wellness Lifestyles, Inc., and Life Extension Foundation Buyers Club (1"The Tan Sheet" June 30, 2003, p. 11). Petition is posted on FDA 2website, with open comment period until Nov. 2. Agency will notify petitioners of final decision by April 15, 2004...

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

RS128804

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel